FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns a method for producing an autologous composition applicable in treating a mammal suffering from connective tissue diseases, selected from connective tissue injury and/or injury, chronic tendinosis, chronic muscle ruptures and chronic degenerative joint disorders, and/or skin disease, which is an inflammatory skin disorder, comprising the steps of producing an anti-inflammatory/anti-catabolic component of an autologous composition containing IL-1ra and TIMP; obtaining a regenerative component of an autologous composition; and mixing the supernatant component of the anti-inflammatory/anti-catabolic component with the thrombocyte-rich plasma component to obtain an autologous composition. Group of inventions also relates to use of an autologous composition for treating connective tissue diseases, and/or skin diseases in a mammal; method of producing said autologous composition.
EFFECT: group of inventions provides reducing the negative catabolic factors.
24 cl, 19 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD, TEST TUBE AND DEVICE FOR MAKING OF COMPOSITIONS FOR WOUND HEALING | 2011 |
|
RU2614722C2 |
METHOD, TEST TUBE AND DEVICE FOR MAKING OF COMPOSITIONS FOR WOUND HEALING | 2011 |
|
RU2667964C1 |
SERUM FRACTION OF THROMBOCYTE-ENRICHED FIBRIN | 2014 |
|
RU2711330C2 |
NANODISPERSED PLASTIC BIOENGINEERING COMPOSITION BASED ON CERIUM DIOXIDE FOR REPLENISHING THE VOLUME OF BONE TISSUE | 2021 |
|
RU2793324C1 |
BIOCOMPLEX TO STIMULATE TISSUE REGENERATION AND REMODELING | 2021 |
|
RU2794464C1 |
METHOD OF PRODUCING PLATELET-ENRICHED FIBRIN MATRIX OF VARIOUS SHAPES AND SIZES | 2023 |
|
RU2811233C1 |
TISSUE COMPOSITION OR ADHESIVE OBTAINED FROM BLOOD COMPOSITION CONTAINING THROMBOCYTES, AND METHOD FOR PREPARING SAID COMPOSITION | 2020 |
|
RU2820448C2 |
DERIVED FROM HUMAN THROMBOCYTE LYSATE, EXTRACELLULAR VESICLES FOR USE IN MEDICINE | 2017 |
|
RU2735139C2 |
METHOD OF PRODUCING THROMBOCYTE-RICH PLASMA AND METHOD FOR PRODUCING THROMBO-FIBBRIN GEL OR CLOT WITH SERUM, CONTAINING GROWTH FACTORS FROM UNSTABILISED VENOUS BLOOD | 2019 |
|
RU2717448C1 |
METHOD FOR TREATMENT OF DEGENERATIVE-DYSTROPHIC DISEASES AND LOCOMOTOR SYSTEM INJURIES CONSEQUENCES | 2016 |
|
RU2618928C1 |
Authors
Dates
2019-12-05—Published
2015-09-30—Filed